GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Shanghai Rongtai Health Technology Corp Ltd (SHSE:603579) » Definitions » EBIT

Shanghai Rongtai Health Technology (SHSE:603579) EBIT : ¥223 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shanghai Rongtai Health Technology EBIT?

Shanghai Rongtai Health Technology's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was ¥37 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥223 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Shanghai Rongtai Health Technology's annualized ROC % for the quarter that ended in Sep. 2024 was 5.50%. Shanghai Rongtai Health Technology's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 12.72%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Shanghai Rongtai Health Technology's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 5.27%.


Shanghai Rongtai Health Technology EBIT Historical Data

The historical data trend for Shanghai Rongtai Health Technology's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Rongtai Health Technology EBIT Chart

Shanghai Rongtai Health Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 332.27 205.01 289.71 208.16 257.60

Shanghai Rongtai Health Technology Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.75 61.80 70.01 53.88 37.29

Competitive Comparison of Shanghai Rongtai Health Technology's EBIT

For the Leisure subindustry, Shanghai Rongtai Health Technology's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Rongtai Health Technology's EV-to-EBIT Distribution in the Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Shanghai Rongtai Health Technology's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Shanghai Rongtai Health Technology's EV-to-EBIT falls into.


;
;

Shanghai Rongtai Health Technology EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥223 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Rongtai Health Technology  (SHSE:603579) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Shanghai Rongtai Health Technology's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=129.488 * ( 1 - 12.32% )/( (2068.457 + 2063.673)/ 2 )
=113.5350784/2066.065
=5.50 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3338.173 - 388.836 - ( 880.88 - max(0, 663.45 - 1939.213+880.88))
=2068.457

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3409.414 - 331.921 - ( 1013.82 - max(0, 720.709 - 1951.34+1013.82))
=2063.673

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Shanghai Rongtai Health Technology's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=149.16/( ( (584.265 + max(606.716, 0)) + (606.411 + max(547.805, 0)) )/ 2 )
=149.16/( ( 1190.981 + 1154.216 )/ 2 )
=149.16/1172.5985
=12.72 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(211.636 + 163.561 + 653.289) - (388.836 + 0 + 32.934)
=606.716

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(158.796 + 135.412 + 614.49) - (331.921 + 0 + 28.972)
=547.805

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Shanghai Rongtai Health Technology's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=222.975/4229.410
=5.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Rongtai Health Technology EBIT Related Terms

Thank you for viewing the detailed overview of Shanghai Rongtai Health Technology's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Rongtai Health Technology Business Description

Traded in Other Exchanges
N/A
Address
No. 1226 ZhuFeng Road, Qingpu District, Shanghai, CHN, 201702
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
Executives
Cao Tao Supervisors
Ying Jian Sen Director
Lin Guang Sheng Director
Lin Qi Director

Shanghai Rongtai Health Technology Headlines

No Headlines